Institute to sign cancer research deal with China

NST:Talks on a joint collaboration to help develop human tissue extraction techniques which will provide a new lease of life for cancer patients are nearing the end.
Institute director-general, Dr Daud Mohamad, said China was one of the pioneer researchers in human tissue development.
He said patients with colon, lung, kidney as well as brain cancer would benefit from the technology.
"Upon the finalisation of the human tissue deal, Mint will move on to the next stage by commercialising the technology."
Some 15,000 cancer-related patients are the beneficiaries of Mint’s 14 radio-pharmaceutical treatment centres in the country.